Venous thromboembolism

VTE · CVRM · 2 drugs · 3 indications

Blood clots in veins. Includes DVT and pulmonary embolism.
Competitive Landscape (2 drugs)
DrugCompanyMechanismModalityRouteStage
REGN7508REGNFactor XI inhibitor (monoclonal antibody)Monoclonal antibodySCPHASE3
LixianaDSNKYFactor Xa inhibitorSmall moleculeORALAPPROVED
Indications (3)
VTE treatment/prevention
Lixiana APPROVED
VTE prevention (post-surgical or medical)
REGN7508 PHASE3
Venous thromboembolism
Lixiana APPROVED
Upcoming Catalysts
Lixiana - Patent Expiration PreparationCOMPETITIVE
DSNKYOngoing
Data from Supabase · Updated 2026-03-24